Related references
Note: Only part of the references are listed.CURRENT CONCEPTS Advances in the Development of Vaccines against Neisseria meningitidis
Lionel K. K. Tan et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Positive effect of the introduction of Haemophilus influenzae type b vaccination in the expanded program on immunization in Cameroon
Denis Massenet et al.
VACCINE (2010)
A dose-range study assessing immunogenicity and safety of one dose of a new candidate meningococcal serogroups A, C, W-135, Y tetanus toxoid conjugate (MenACWY-TT) vaccine administered in the second year of life and in young children
M. Knuf et al.
VACCINE (2010)
Setting priorities for global mental health research
Mark Tomlinson et al.
BULLETIN OF THE WORLD HEALTH ORGANIZATION (2009)
Quadrivalent Meningococcal Vaccination of Adults: Phase III Comparison of an Investigational Conjugate Vaccine, MenACWY-CRM, with the Licensed Vaccine, Menactra
Keith S. Reisinger et al.
CLINICAL AND VACCINE IMMUNOLOGY (2009)
Phase III Comparison of an Investigational Quadrivalent Meningococcal Conjugate Vaccine with the Licensed Meningococcal ACWY Conjugate Vaccine in Adolescents
Lisa A. Jackson et al.
CLINICAL INFECTIOUS DISEASES (2009)
Safety and Immunogenicity of a Tetravalent Polysaccharide Vaccine Against Meningococcal Disease
Pei-Lan Shao et al.
JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION (2009)
Research priorities for health of people with disabilities: an expert opinion exercise
Mark Tomlinson et al.
LANCET (2009)
Immunogenicity and Immune Memory of a Nonadjuvanted Quadrivalent Meningococcal Glycoconjugate Vaccine in Infants
Kirsten P. Perrett et al.
PEDIATRIC INFECTIOUS DISEASE JOURNAL (2009)
Research Priorities to Reduce Global Mortality From Newborn Infections by 2015
Rajiv Bahl et al.
PEDIATRIC INFECTIOUS DISEASE JOURNAL (2009)
Prospects and challenges with introduction of a mono-valent meningococcal conjugate vaccine in Africa
Brown J. Okoko et al.
VACCINE (2009)
Incremental system costs of introducing combined DTwP-hepatitis B-Hib vaccine into national immunization services in Ethiopia
Ulla K. Griffiths et al.
VACCINE (2009)
Immunogenicity, reactogenicity and persistence of meningococcal A, C, W-135 and Y-tetanus toxoid candidate conjugate (MenACWY-TT) vaccine formulations in adolescents aged 15-25 years
Lars Ostergaard et al.
VACCINE (2009)
Meningococcal disease and prevention at the Hajj
Ray Borrow
TRAVEL MEDICINE AND INFECTIOUS DISEASE (2009)
Setting Research Priorities To Reduce Global Mortality from Childhood Diarrhoea by 2015
Olivier Fontaine et al.
PLOS MEDICINE (2009)
Setting priorities in global child health research investments: Universal challenges and conceptual framework
Igor Rudan et al.
CROATIAN MEDICAL JOURNAL (2008)
Setting Priorities in Global Child Health Research Investments: Guidelines for Implementation of CHNRI Method
Igor Rudan et al.
CROATIAN MEDICAL JOURNAL (2008)
The development of a new heptavalent diphtheria-tetanus-whole cell pertussis-hepatitis B-Hoemophilus influenzae type b-Neisseria meningitidis serogroups A and C vaccine:: a randomized dose-ranging trial of the conjugate vaccine components
S. Gatchatian et al.
INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES (2008)
A Phase II, Randomized Study on an Investigational DTPw-HBV/Hib-MenAC Conjugate Vaccine Administered to Infants in Northern Ghana
Abraham Hodgson et al.
PLOS ONE (2008)
Immunogenicity and reactogenicity of a booster dose of a novel combined Haemophilus influenzae type b-Neisseria meningitidis serogroup C-tetanus toxoid conjugate vaccine given to toddlers of 13-14 months of age with antibody persistence up to 31 months of age
Juan C. Tejedor et al.
PEDIATRIC INFECTIOUS DISEASE JOURNAL (2008)
Meningococcal carriage in the African meningitis belt
Caroline L. Trotter et al.
LANCET INFECTIOUS DISEASES (2007)
An economic evaluation of thermostable vaccines in Cambodia, Ghana and Bangladesh
Ann Levin et al.
VACCINE (2007)
Safety, immunogenicity, and antibody persistence of a new meningococcal group A conjugate vaccine in healthy Indian adults
Nilima Kshirsagar et al.
VACCINE (2007)
Effectiveness of a trivalent serogroup A/CIW135 meningococcal polysaccharide vaccine in Burkina Faso, 2003
Montse Soriano-Gabarro et al.
VACCINE (2007)
Childhood pneumonia and diarrhoea: setting our priorities right
Igor Rudan et al.
LANCET INFECTIOUS DISEASES (2007)
A review of vaccine research and development: Meningococcal disease
Marc P. Girard et al.
VACCINE (2006)
Co-coverage of preventive interventions and implications for child-survival strategies: evidence from national surveys
CG Victora et al.
LANCET (2005)
Safety, immunogenicity, and immune memory of a novel meningococcal (groups A, C, Y, and W-135) polysaccharide diphtheria toxoid conjugate vaccine (MCV-4) in healthy adolescents
H Keyserling et al.
ARCHIVES OF PEDIATRICS & ADOLESCENT MEDICINE (2005)
Recent developments in Neisseria meningitidis group A conjugate vaccines
CE Frasch
EXPERT OPINION ON BIOLOGICAL THERAPY (2005)
Decline in invasive pneumococcal disease after the introduction of protein-polysaccharide conjugate vaccine
CG Whitney et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
Herd immunity from meningococcal serogroup C conjugate vaccination in England: database analysis
ME Ramsay et al.
BRITISH MEDICAL JOURNAL (2003)
W135 meningococcal carriage in association with the Hajj pilgrimage 2001: the Singapore experience
A Wilder-Smith
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2003)
Carriage of serogroup C meningococci 1 year after meningococcal C conjugate polysaccharide vaccination
MCJ Maiden et al.
LANCET (2002)
Efficacy of meningococcal serogroup C conjugate vaccine in teenagers and toddlers in England
ME Ramsay et al.
LANCET (2001)
Emergency vaccination against epidemic meningitis in Ghana: implications for the control of meningococcal disease in West Africa
CW Woods et al.
LANCET (2000)
Share Paper
